Your browser doesn't support javascript.
loading
MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report.
Choi, Wonyoung; Jeong, Kyung-Chae; Park, Seog-Yun; Kim, Sunshin; Kang, Eun Hye; Hwang, Mihwa; Han, Ji-Youn.
Affiliation
  • Choi W; Research Institute, National Cancer Center, Goyang, Korea.
  • Jeong KC; Center for Clinical Trials, National Cancer Center, Goyang, Korea.
  • Park SY; Research Institute, National Cancer Center, Goyang, Korea.
  • Kim S; Incurix Co., Ltd., Goyang, Korea.
  • Kang EH; Department of Pathology, National Cancer Center, Goyang, Korea.
  • Hwang M; Research Institute, National Cancer Center, Goyang, Korea.
  • Han JY; Research Institute, National Cancer Center, Goyang, Korea.
Transl Lung Cancer Res ; 11(9): 1967-1972, 2022 Sep.
Article in En | MEDLINE | ID: mdl-36248327
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2022 Document type: Article Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2022 Document type: Article Country of publication: China